Technology | 2015.09.03
CRISPR Cash: Intellia The Latest Gene-Editing Firm To Nab Big Money - Xconomy
| Xconomy | CRISPR Cash: Intellia The Latest Gene- Editing Firm To Nab Big Money Xconomy As top scientists head toward a summit later this year to hammer out rules governing the use of gene editing , companies developing one form of the technology, known as CRISPR-Cas9, for human medicine continue to raise cash hand over fist. The latest is ... Intellia raises $70 million for gene- editing treatments Gene- Editing Startup Intellia Therapeutics Secures $70M Series B Intellia Therapeutics Secures $70 Million in Series B Financing |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]sh-intellia-the-latest-gene-ed
